High Burden of Viral Respiratory Co-infections in a Cohort of Children with Suspected Pulmonary Tuberculosis
Overview
Authors
Affiliations
Background: The presentation of pulmonary tuberculosis (PTB) in young children is often clinically indistinguishable from other common respiratory illnesses, which are frequently infections of viral aetiology. As little is known about the role of viruses in children with PTB, we investigated the prevalence of respiratory viruses in children with suspected PTB at presentation and follow-up.
Methods: In an observational cohort study, children < 13 years were routinely investigated for suspected PTB in Cape Town, South Africa between December 2015 and September 2017 and followed up for 24 weeks. Nasopharyngeal aspirates (NPAs) were tested for respiratory viruses using multiplex PCR at enrolment, week 4 and 8.
Results: Seventy-three children were enrolled [median age 22.0 months; (interquartile range 10.0-48.0); 56.2% male and 17.8% HIV-infected. Anti-tuberculosis treatment was initiated in 54.8%; of these 50.0% had bacteriologically confirmed TB. At enrolment, ≥1 virus were detected in 95.9% (70/73) children; most commonly human rhinovirus (HRV) (74.0%). HRV was more frequently detected in TB cases (85%) compared to ill controls (60.6%) (p = 0.02). Multiple viruses were detected in 71.2% of all children; 80% of TB cases and 60.6% of ill controls (p = 0.07). At follow-up, ≥1 respiratory virus was detected in 92.2% (47/51) at week 4, and 94.2% (49/52) at week 8.
Conclusions: We found a high prevalence of viral respiratory co-infections in children investigated for PTB, irrespective of final PTB diagnosis, which remained high during follow up. Future work should include investigating the whole respiratory ecosystem in combination with pathogen- specific immune responses.
Health-related quality of life in children with presumptive TB.
Anthony M, Johnson L, van Niekerk M, Mfwaze A, Bavuma B, Hesseling A IJTLD Open. 2024; 1(11):495-500.
PMID: 39544879 PMC: 11558787. DOI: 10.5588/ijtldopen.24.0355.
SARS-CoV-2 coinfection in children with severe airway obstruction due to pulmonary tuberculosis.
Goussard P, van Wyk L, Venkatakrishna S, Rabie H, Schubert P, Frigati L Pediatr Pulmonol. 2024; 59(12):3446-3456.
PMID: 39185631 PMC: 11601029. DOI: 10.1002/ppul.27232.
Respiratory adenovirus infections in children: a focus on Africa.
van der Zalm M, Sam-Agudu N, Verhagen L Curr Opin Pediatr. 2024; 36(3):342-348.
PMID: 38465727 PMC: 11062604. DOI: 10.1097/MOP.0000000000001335.
and SARS-CoV-2 co-infections: The knowns and unknowns.
Chiok K, Dhar N, Banerjee A iScience. 2023; 26(5):106629.
PMID: 37091987 PMC: 10082467. DOI: 10.1016/j.isci.2023.106629.
Transcriptomics for child and adolescent tuberculosis.
Kaforou M, Broderick C, Vito O, Levin M, Scriba T, Seddon J Immunol Rev. 2022; 309(1):97-122.
PMID: 35818983 PMC: 9540430. DOI: 10.1111/imr.13116.